Carol Stuckley

Insider Reports History

Location
Cheshire, United Kingdom
Signature
/s/ Iqbal Hussain, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carol Stuckley:

Company Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Director Share Option (right to buy) 40,000 20 Jun 2025 Direct
Epizyme, Inc. Director Common Stock, par value $0.0001 0 $1.41 12 Aug 2022 Direct

Insider Reports Filed by Carol Stuckley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTA Centessa Pharmaceuticals plc 20 Jun 2025 1 $0 4 Director 24 Jun 2025, 16:11
CNTA Centessa Pharmaceuticals plc 25 Jun 2024 1 $0 4 Director 27 Jun 2024, 16:31
CNTA Centessa Pharmaceuticals plc 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 17:08
/report/000089924322028856-stuckley-carol-2022-08-12 Epizyme, Inc. 12 Aug 2022 1 $0 4 Director 16 Aug 2022, 18:54
CNTA Centessa Pharmaceuticals plc 30 Jun 2022 1 $0 4 Director 05 Jul 2022, 19:00
/report/000089924322018839-stuckley-carol-2022-05-17 Epizyme, Inc. 17 May 2022 2 $0 4 Director 19 May 2022, 16:29
/report/000089924321045210-stuckley-carol-2021-11-16 Epizyme, Inc. 16 Nov 2021 2 $0 4 Director 18 Nov 2021, 07:20
/report/000089924321045207-stuckley-carol-2021-11-16 Epizyme, Inc. 16 Nov 2021 0 $0 3 Director 18 Nov 2021, 07:15
CNTA Centessa Pharmaceuticals plc 27 May 2021 0 $0 3 Director 27 May 2021, 20:31